tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Avadel Pharmaceuticals sees Q4 revenue $50M, consensus $52.7M

The company said, “Fourth quarter revenue was impacted by approximately $6.0 million due to an estimated 1.5 fewer weeks of inventory in the channel at December 31, 2024, compared to September 30, 2024.”

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1